张健，1962年生，籍贯山西万荣。著名心血管病专家，永利集团3044官网欢迎您阜外医院主任医师，博士生导师。1979-1984年兰州医学院医疗系毕业并获学士学位。1994-1998年中国协和医科大学内科学专业毕业并获博士学位。2000年副主任医师/硕导(2001)，2006年主任医师/博导(2008)。主要从事心血管病学教学、临床和研究。在心力衰竭和心肌病，心血管病疑难危重症，冠心病，心肌炎等的临床和研究上有深刻造诣。承担了国家十三五等重大项目。在国际学术界有良好的声望。

心力衰竭、心肌病/心肌炎诊治和机制；心脏淀粉样变精准诊疗；心血管急危重症救治；疑难心血管病诊治；心衰和心肌病医疗质量管理；新型心衰生物标志物；心血管新药研发与临床试验；心血管病中西医结合。

1. Zhao L#, Zhao X, Tian P, Liang L, Huang B, Huang L, Feng J, Zhang Y*, Zhang J*. Prognostic Utility of The Prognostic Nutritional Index Combined with Serum Sodium Level in Patients with Heart Failure. Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1894-1902. (IF=4.666)

2. Carubelli V#*, Zhang Y#, Metra M, Lombardi C, Felker GM, Filippatos G, O'Connor CM, Teerlink JR, Simmons P, Segal R, Malfatto G, La Rovere MT, Li D, Han X, Yuan Z, Yao Y, Li B, Lau LF, Bianchi G, Zhang J*; Istaroxime ADHF Trial Group. Treatment with 24 Hour Is Taroxime Infusion in Patients Hospitalised for Acute Heart Failure: A Randomised, Placebo-controlled Trial. Eur J Heart Fail. 2020 Sep;22(9):1684-1693. (IF=11.627)

3. Ponnusamy M#, Liu F#, Zhang YH#, Li RB#, Zhai M, Liu F, Zhou LY, Liu CY, Yan KW, Dong YH, Wang M, Qian LL, Shan C, Xu S, Wang Q, Zhang YH, Li PF, Zhang J*, Wang K*. Long non-Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair. Circulation. 2019 Jun 4;139(23):2668-2684. (IF=23.603, ESI)

4. Zhang Y#, Zhang J#*, Butler J, Yang X, Xie P, Guo D, Wei T, Yu J, Wu Z, Gao Y, Han X, Zhang X, Wen S, Anker SD, Filippatos G, Fonarow GC, Gan T, Zhang R; China-HF Investigators. Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry. J Card Fail. 2017 Dec;23(12):868-875. (IF=3.987)

5. Wang Y#, Zhang Y*, An T, Zhang R, Zhao X, Liu N, Yin S, Gan T, Liang T, Huang Y, Zhou Q, Zhang J*. ErbB4 Gene Polymorphism Is Associated With the Risk and Prognosis of Congestive Heart Failure in a Northern Han Chinese Population. J Card Fail. 2016 Sep;22(9):700-9. (IF=3.510)

6. Wang K#, Zhou LY, Wang JX, Wang Y, Sun T, Zhao B, Yang YJ, An T, Long B, Li N, Liu CY, Gong Y, Gao JN, Dong YH, Zhang J*, Li PF*. E2F1-dependent miR-421 Regulates Mitochondrial Fragmentation And Myocardial Infarction By Targeting Pink1. Nat Commun. 2015 Jul 17;6:7619. (IF=12.124)

7. Zhang Y#, Zhang R#, An T, Huang Y, Guo X, Yin S, Wang Y, Ji S, Lv R, Zhang J*, Maisel A. The Utility of Galectin-3 For Predicting Cause-specific Death In Hospitalized Patients with Heart Failure. J Card Fail. 2015 Jan;21(1):51-9. (IF=3.583, F1000)

8. Zou CH#, Zhang J*, Zhang YH, Wei BQ, Wu XF, Zhou Q, Huang Y, Zhang RC, Lv R. Frequency And Predictors of Normalization of Left Ventricular Ejection Fraction in Recent-onset Nonischemic Cardiomyopathy. Am J Cardiol. 2014 May 15;113(10):1705-10. (IF=4.089)

9.Li X#*, Zhang J#*, Huang J*, Ma A, Yang J, Li W, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R; Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group. A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of The Effects of Qili Qiangxin Capsules in Patients with Chronic Heart Failure. J Am Coll Cardiol. 2013 Sep 17;62(12):1065-1072. (IF=14.086, C100)

10.Gao R#, Zhang J#, Cheng L#, Wu X, Dong W, Yang X, Li T, Liu X, Xu Y, Li X*, Zhou M*. A Phase II, Randomized, Double-blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of The Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients with Chronic Heart Failure. J Am Coll Cardiol. 2010 May 4;55(18):1907-14. (IF=12.640, C100)